OD6, Jindalee and Resolution Lead a Resource-Heavy Rally

OD6 Metals (ASX:OD6) led the board with a 75.00% jump after reporting high-grade fluorspar results from Nevada, including assays above 53% CaF2. Investors cared because the project sits in a mineral the US still imports heavily. Jindalee Lithium (ASX:JLL) surged 63.10% after agreeing to spin its McDermitt project into a Nasdaq-listed vehicle at a pro forma value of about US$571 million. Resolution Minerals (ASX:RML) climbed 50.00% as its Idaho antimony project won FAST-41 status, which matters because it can speed up government approvals. At the other end, Orora (ASX:ORA) dropped 20.59% after cutting guidance for Saverglass, while Recharge Metals (ASX:REC) fell 19.35% and Beetaloo Energy (ASX:BTL) lost 15.71% as fresh capital raising plans raised dilution fears.

Critical minerals and gold kept buyers busy

Small and mid-cap miners filled most of the winners list. The common thread was simple: many released new drilling results that suggested more metal in the ground than the market had priced in. St George Mining (ASX:SGQ) rose 8.33% on thick rare earth and niobium hits in Brazil. Aldoro Resources (ASX:ARN) added 5.49% after confirming 537 metres of continuous mineralisation in Namibia. Magnum Mining and Exploration (ASX:MGU) jumped 40.00% as investors responded to both a large Brazilian rare earth drilling plan and very high gold assays at its Parker project in Arizona.

Gold names were also strong. Saturn Metals (ASX:STN) rose 23.40% after a record 277g/t gold intercept at Apollo Hill. Torque Metals (ASX:TOR) gained 18.60% as drilling extended mineralisation well beyond its current resource. Aurum Resources (ASX:AUE) climbed 11.67% after lifting the Napié resource by 34%. In plain terms, investors bought these stocks because each update pointed to a bigger mine, a longer mine life, or both.

Not every jump held perfectly after trading reopened. In several names, early gains faded later in the session, which usually means short-term traders sold into strength. In others, buying stayed firm through the week. That steadier pattern was visible in names such as Telix Pharmaceuticals (ASX:TLX), Pro Medicus (ASX:PME) and Southern Cross Gold (ASX:SX2), where buyers kept paying up after the first move.

Deals, bids and balance sheets moved prices fast

Corporate activity was another major driver. Predictive Discovery and Robex Resources (ASX:RXR) confirmed their merger is now unconditional, sending Robex up 10.21% for the week. Investors liked the promise of a larger West African gold producer with less need for extra equity. Magellan Financial Group (ASX:MFG) moved little, down 0.84%, even though its planned full acquisition of Barrenjoey was received well. That muted share move suggests investors want to see approvals and final terms before pushing harder.

Matrix Composites & Engineering (ASX:MCE) edged up 1.39% after granting exclusivity to a bidder at $0.40 a share. Insignia Financial (ASX:IFL) was broadly flat, up 0.42%, after clearing a key foreign investment approval. Ainsworth Game Technology (ASX:AGI) rose 8.91% when its board backed a proportional bid at $1.30 a share. In takeover situations, the key question is always the same: will the deal finish on the announced terms? When that answer is still unclear, share prices often stop short of the offer price.

Fresh financing had mixed results. Rox Resources (ASX:RXL) added 5.68% after locking in a $350 million debt package for Youanmi, because debt from major banks reduced doubt about whether the project can be built. By contrast, Beetaloo Energy’s raising hurt the stock because new shares at a discount can water down existing holders. WA Kaolin (ASX:WAK), still suspended, laid out a deeply dilutive rights offer that points to how hard balance-sheet stress can be on shareholders.

Healthcare and tech names were selective

Healthcare gains came from concrete milestones rather than broad sector buying. Telix Pharmaceuticals (ASX:TLX) rose 13.05% on both revenue growth and FDA acceptance of its glioma imaging application. That matters because the regulator has now set a review date for September 2026. Radiopharm Theranostics (ASX:RAD) gained 4.76% after securing Siemens Healthineers as a supply partner for a late-stage brain metastases trial. EBR Systems (ASX:EBR) climbed 13.56% after implant numbers more than doubled in the quarter, which gave investors a clearer read on early sales demand.

Among industrial tech names, Pro Medicus (ASX:PME) advanced 6.80% on a new A$23 million US contract. DroneShield (ASX:DRO) fell 11.70% despite record quarterly cash receipts and strong committed revenue. The fall suggests investors were uneasy about the leadership change, or had hoped for even more after the company’s earlier run. PlaySide Studios (ASX:PLY) gained 25.00% after MOUSE: P.I. For Hire passed 1.5 million wishlists ahead of launch, a sign that demand could translate into sales if players actually buy the game after release.

Energy, property and financials rounded out the week

Fortescue (ASX:FMG) was almost unchanged, up 0.05%, after bringing forward its diesel-free target in the Pilbara. The strategic plan was ambitious, but the stock barely moved because the market often waits for delivery rather than rewarding long-range targets straight away. QPM Energy (ASX:QPM) added 3.23% after securing NAIF credit approval for Isaac Power Station. Invictus Energy (ASX:IVZ) was stronger, up 24.44%, after renewing its environmental approval in Zimbabwe and moving closer to a production sharing agreement.

Property and financial names were steadier. Aspen Group (ASX:APZ) rose 8.70% on stronger earnings and low gearing. GPT Group (ASX:GPT) gained 4.49% after reporting larger assets under management and high occupancy. Bendigo and Adelaide Bank (ASX:BEN) advanced 13.54% as it paired earnings growth with cost-saving deals. Bank of Queensland (ASX:BOQ) rose 9.26% after striking a $3.7 billion equipment finance partnership with Challenger. Investors liked it because it frees up capital and opens the door to buybacks and a special dividend.

Still, the week’s weakest reactions came where investors were given a clear reason to worry. Orora cut profit expectations because war-related disruption hit its Saverglass business. Elanor Investors Group (ASX:ENN) stayed flat at 0.00% but remains under pressure as it works through recapitalisation and going-concern risk, meaning there is still doubt about how easily it can keep operating under its current debt load. Cue Energy (ASX:CUE) slipped 6.67% as its board urged holders to reject Horizon Oil’s bid, leaving the company in a contested and uncertain position.